Origin Agritech Receives Full US$2.8 Million from Previously Announced Private Placement at US$1.40 Per Share

Ordinary shares outstanding increased from 12,144,586 to 14,144,586 following the completed issuance.

Rhea-AI Summary

Origin Agritech (NASDAQ: SEED) has received the full US$2.8 million from its previously announced private placement and issued all shares to investors. The transaction involved 2,000,000 ordinary shares at US$1.40 each, with no warrants or placement agent fees, leaving substantially all proceeds for the business. Two individuals and one investment company purchased on identical terms under three Securities Purchase Agreements dated February 1, 2026.

The proceeds are designated for working capital, expanded research and development, and debt repayment; Origin expects to prioritize working capital and research and development. The financing follows the sale of subsidiary Xinjiang Originbo and the leaseback of its seed production facility, which keeps Origin's production capacity and main personnel in place.

4 points · 1 major

MixediHow this balance works

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

1 major · 1 point

Hollow bars mark forward-looking points. How the balance works

Positive

• Major pointUS$2,800,000 gross proceeds received in full add to Origin's resources. 33% of market cap
• Minor pointNo warrants or placement agent fees leave substantially all placement proceeds for the business.
• Minor point. Forward-looking: it has not happened yet and may not happen.Expanded research and development is a planned use of proceeds; Origin expects to prioritize it alongside working capital.
• Minor pointXinjiang facility leaseback keeps production capacity and main personnel in place following the subsidiary sale.

Negative

• Major point2,000,000 ordinary shares issued at US$1.40 each dilute holders, increasing outstanding shares from 12,144,586 to 14,144,586.

News Explained

Following the completed issuance, Origin Agritech has 14,144,586 ordinary shares outstanding, up from 12,144,586; the larger share count reduces existing holders’ percentage ownership, absent offsetting changes.

Key Figures

Gross proceeds: US$2,800,000 Shares issued: 2,000,000 ordinary shares Price per share: US$1.40 +1 more

Gross proceeds

US$2,800,000

Received in full from the completed private placement

Shares issued

2,000,000 ordinary shares

Completed private placement

Price per share

US$1.40

Private placement

Ordinary shares outstanding

12,144,586 before; 14,144,586 after

Before and after issuance

Historical Context

1 past event · Latest: Oct 01

1 event

1. Oct 01

   Subsidiary sale

   24h Move

   -14.4%

   Sold 70.5184% of Xinjiang Originbo for RMB 108 million with a five-year leaseback.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

private placement, securities purchase agreements

2 terms

private placement financial

"received the full US$2,800,000 gross subscription amount from its previously announced private placement"

A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.

securities purchase agreements financial

"under three Securities Purchase Agreements dated February 1, 2026"

A securities purchase agreement is a legal contract that spells out the terms when a company sells stocks, bonds, or other investment instruments to buyers. It lays out price, how many securities change hands, any promises or protections for each side, and when the sale is completed—like a detailed sales contract for investments. Investors care because it determines ownership stakes, potential dilution, rights attached to the securities, and conditions that affect the company’s future value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

No warrants and no placement agent fees; proceeds fund working capital, R&D, and debt reduction ahead of the Company's fiscal 2027 commercialization programs

BEIJING, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Origin Agritech Limited (NASDAQ: SEED) ("Origin" or the "Company"), a leading Chinese agricultural technology company, today announced that it has received the full US$2,800,000 gross subscription amount from its previously announced private placement of 2,000,000 ordinary shares at US$1.40 per share and has issued all of the shares to the investors. The investors, two individuals and one investment company, purchased under three Securities Purchase Agreements dated February 1, 2026, each on the same terms and at the same price.

The placement carried no warrants and no placement agent fees, so substantially all of the proceeds go to the business. The completed placement adds to the Company's resources following the recent sale of its subsidiary, Xinjiang Originbo, and the leaseback of that seed production facility. This arrangement keeps Origin's production capacity and main personnel in place.

"We raised this capital at US$1.40 per share with no warrants and no intermediaries taking a cut, so nearly every dollar goes to work," said Weibin Yan, Chief Executive Officer of Origin. “With our Xinjiang production base running under the leaseback, we are putting these funds behind the breeding and trait programs in our commercial pipeline and the working capital to bring those varieties to market. We thank our investors, who took the time to understand a seed and biotechnology business before they committed."

Transaction Summary

• Shares issued: 2,000,000 ordinary shares, no par value
• Price: US$1.40 per share
• Gross proceeds: US$2,800,000, received in full
• Warrants and placement agent fees: none
• Investors: two individual investors and one investment company, under three Securities Purchase Agreements dated February 1, 2026, each on the same terms and price; to the Company's knowledge, none is an affiliate of the Company or any of its directors or executive officers
• Board approval: December 12, 2025
• Ordinary shares outstanding: 12,144,586 before the issuance and 14,144,586 after
• Share registration: registered in the investors' names with the Company's transfer agent by book entry, with physical certificates available on request
• Use of proceeds: general working capital, expansion of research and development activities, including the operations of the Company's subsidiaries and affiliated entities, and repayment of debt; the Company expects to prioritize working capital and R&D

The Company furnished the forms of the three Securities Purchase Agreements to the U.S. Securities and Exchange Commission (the "SEC") as exhibits to its Form 6-K dated February 2, 2026, available at: https://www.sec.gov/Archives/edgar/data/1321851/000110465926009252/tm264783d1_6k.htm.

About Origin Agritech Limited

Origin Agritech Limited, founded in 1997 and headquartered at the Origin R&D Center in Songzhuang, Tongzhou, Beijing, is a leading Chinese agricultural technology company. In crop seed biotechnology, Origin Agritech's phytase corn was the first transgenic corn to receive a Biosafety Certificate from China's Ministry of Agriculture. Over the years, Origin has established a robust biotechnology seed pipeline, including products with glyphosate tolerance and Bt (pest resistance) traits. For further information, please visit the Company's website at originagritech.com. The Company also maintains an X account to update investors on Company and industry developments, available at https://x.com/origin_agritech.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the Company's intended use of proceeds, the timing and progress of its fiscal 2027 commercialization programs, the breeding and trait programs behind its commercial pipeline, expected revenue growth, regulatory and commercial milestones for new and biotechnology-derived varieties, operating expenses, and the Company's strategic plan and goals. Words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "will," "would," "target," and similar expressions identify forward-looking statements. These statements involve known and unknown risks and uncertainties, including risks related to the Company's ability to deploy the net proceeds as intended, delays in or failure to achieve regulatory and commercial milestones, grower adoption of the Company's varieties, seed production yields and weather conditions, competitive variety introductions, pricing pressure in the Chinese seed market, regulatory and agricultural policy developments in China, currency fluctuation, and the Company's ability to fund and execute the plans described above, which may cause actual results to differ materially from those expressed or implied. Forward-looking statements are not guarantees of future performance. Origin Agritech undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by securities and other applicable laws.

For more information, please contact:

Origin Agritech Limited Contact:
Kate Lang (Mandarin/English)
Director of Investor Relations
Phone: +86 186-1839-3368
Email: bing.lang@originseed.com.cn

Investor Relations Contact:
Matthew Abenante, IRC
President
Strategic Investor Relations LLC
Tel: 347-947-2093
Email: matthew@strategic-ir.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much did Origin Agritech raise in its completed private placement, and at what price?

Origin Agritech received US$2,800,000 in gross proceeds from issuing 2,000,000 ordinary shares at US$1.40 per share. All shares have been issued to the investors. The placement included no warrants and incurred no placement agent fees.

Who invested in Origin Agritech's private placement?

The investors were two individuals and one investment company, purchasing under three Securities Purchase Agreements on the same terms and at the same price. To Origin's knowledge, none is an affiliate of the company or any of its directors or executive officers.